loadpatents
Patent applications and USPTO patent grants for LI; Lingyin.The latest application filed is for "enpp1 inhibitors and methods of modulating immune response".
Patent | Date |
---|---|
ENPP1 Inhibitors and Methods of Modulating Immune Response App 20220289775 - LI; Lingyin ;   et al. | 2022-09-15 |
ENPP1 Inhibitors and Their Use for the Treatment of Cancer App 20210369747 - LI; Lingyin ;   et al. | 2021-12-02 |
Peptide-presenting surfaces for long-term culture of pluripotent cells Grant 9,006,394 - Kiessling , et al. April 14, 2 | 2015-04-14 |
Peptide-presenting Surfaces For Long-term Culture Of Pluripotent Cells App 20140287505 - Kiessling; Laura Lee ;   et al. | 2014-09-25 |
Peptide-presenting surfaces for long-term culture of pluripotent cells Grant 8,648,170 - Kiessling , et al. February 11, 2 | 2014-02-11 |
Peptide-presenting Surfaces For Long-term Culture Of Pluripotent Cells App 20100087004 - Kiessling; Laura Lee ;   et al. | 2010-04-08 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.